New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GOOG;EMC;VMW;INTC;GILD;FRX From The Last 14 Days
Check below for free stories on GOOG;EMC;VMW;INTC;GILD;FRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 8, 2014
15:52 EDTGOOGGoogle Glass being tested by Air Force, VentureBeat says
The “BATMAN," or Battlefield Air Targeting Man-Aided (K)nowledge, team of the Air Force are beta testing Google Glass for possible use on the battlefield, reported VentureBeat. Himax Technologies (HIMX) is a supplier of components for Glass. Reference Link
13:27 EDTGOOGGoogle, Citrix to collaborate on Chromebooks
Subscribe for More Information
08:08 EDTINTC, GOOGCost to Apple, Google, Intel, of 'no-poaching' deal may be high, DealBook says
Some of the of the biggest names in tech, including Apple (AAPL), Google (GOOG), Intel (INTC)and Adobe (ADBE), are at the center of a class-action suit that seeks $9B as compensation for employees who contend the tech giants colluded to prevent their employees from being hired at rivals, reported The New York Times' DealBook. Reference Link
07:45 EDTGOOGSkybox takeover report could pressure DigitalGlobe, says Piper Jaffray
Subscribe for More Information
07:12 EDTGOOGGoogle in early talks to buy Skybox Imaging, The Information reports
Subscribe for More Information
06:48 EDTGOOGGoogle Glass catching on with companies, organizations, NY Times reports
Subscribe for More Information
06:40 EDTGOOGAmazon Fire TV takes top spot on Amazon's best sellers list, TechCrunch reports
Subscribe for More Information
06:07 EDTGOOGMicrosoft investing in 'invisible user interface' technology, WSJ reports
Subscribe for More Information
April 7, 2014
14:18 EDTGOOGGoogle licenses booking software from Expedia-backed startup, Bloomberg says
Tech giant Google (GOOG), which has been bolstering its investments in travel, is now licensing hotel-booking software from Room 77, a startup backed by Expedia (EXPE), reported Bloomberg, citing a letter sent to Room 77 shareholders that was obtained by the news service. Other online travel agencies include Priceline Group (PCLN) and Orbitz Worldwide (OWW). Reference Link
10:00 EDTINTCOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
09:34 EDTGILDActive equity options trading on open
Subscribe for More Information
08:31 EDTGILDGilead announecs FDA priority review designation for Ledipasvir/Sofosbuvir
Gilead Sciences announced that the U.S. Food and Drug Administration has granted priority review to the company’s New Drug Application for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults. Gilead filed the NDA for LDV/SOF on February 10, and the FDA has set a target action date under the Prescription Drug User Fee Act of October 10. The FDA has also assigned LDV/SOF a Breakthrough Therapy designation.
07:55 EDTGOOGGoogle looks to appeal YouTube blackout in Turkey, WSJ says
Subscribe for More Information
07:16 EDTGOOGRetailers muscle into competitive mobile payment market, Reuters says
Subscribe for More Information
06:36 EDTGOOGApple's sales force worried about iPhone outlook, Re/code reports
Apple's (AAPL) sales force has been worried about weakness in the iPhone's market share, amid strong competition from Google's (GOOG) Android operating system, a document presented in a court case showed, Re/code reported on Friday. According to the internal Apple document, the only portions of the smartphone market showing growth were large devices costing more than $300 or devices that cost less than $300, the website stated. Reference Link
05:56 EDTGOOGStocks with implied volatility movement; GOOG XLK
Subscribe for More Information
05:55 EDTINTCIntel upgraded to Outperform from Sector Perform at Pacific Crest
Pacific Crest upgraded its rating on Intel (INTC) shares to Outperform with a $31 price target citing improving corporate PC demand and expectations the company's Grantley server platform will drive spending at traditional IT customers in 2015. Shares of Intel closed Friday down 25c to $26.16.
April 6, 2014
17:48 EDTGOOGGoogle set to announce Android TV, The Verge says
Subscribe for More Information
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use